Erasmus Schneider

Researcher investigates multi-drug resistance of cancer cells

The World Within Reach
Contact the Office of Media Relations at (518) 956-8150
 

Erasmus Schneider

Associate Professor
School of Public Health
Department: Biomedical Sciences

Expertise:
DNA analysis; cancer; drug resistance; laboratory testing techniques

Campus phone: (518) 474-2088
Campus email: eschneider@albany.edu

Biography:

Erasmus Schneider is an associate professor of biomedical sciences at UAlbany's School of Public Health and associate director for research and technology at the Wadsworth Center.

Schneider joined the Wadsworth Center in 1995 as a research scientist when he established an externally funded research program to investigate multi-drug resistance of cancer cells. This research resulted in numerous peer-reviewed publications and presentations at major conferences. Over the years he has continued to work in the area of cancer cell drug resistance, expanding into drugs targeting the folate pathway and DNA precursor synthesis. He was a grant reviewer for the American Cancer Society and currently is a member of its Council for Extramural Research.

From 2007 to 2013 Dr. Schneider was the director of the Center’s Division of Translational Medicine, and in 2013 assumed his current role as the Center’s Associate Director for Research and Technology. In that role he is, among other things, overseeing the Center’s scientific core facilities and internal research funding programs.

Dr. Schneider is also the section head for Oncology in the Clinical Laboratory Reference System. In that position he is responsible for the review of laboratory developed tests submitted by N.Y.S. permitted laboratories in the area of Oncology, and for conducting proficiency testing for serum tumor markers, human papillomavirus, molecular oncology and fetal defect markers. He is particularly interested in the technical and quality control challenges posed by the advanced molecular techniques used for the diagnosis, prognosis and prediction of therapeutic response of cancer.